Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists, inhibitors |
Mechanism CysLT antagonists(Cysteinyl leukotriene receptor antagonists), LTB4 inhibitors(leukotriene B4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Age Related Macular Degeneration | Preclinical | United States | 12 Aug 2024 | |
Diabetic Retinopathy | Preclinical | United States | 12 Aug 2024 | |
Vernal Keratoconjunctivitis | Preclinical | United States | 12 Aug 2024 | |
Uveitis | Preclinical | - | - |